• Norepinephrine to Angiotensin II Ratio in Vasodilatory Hypot

  2026-07-29

  This article analyzes a post-hoc study of the ARAMIS trial, which establishes a clinically relevant conversion ratio between norepinephrine and angiotensin II in patients with vasodilatory hypotension. The findings provide a basis for standardized vasopressor dosing and inform experimental models in cardiovascular research.

• Ruthenium Red: Applied Protocols for Ca2+ Transport Inhibiti

  2026-07-29

  Ruthenium Red stands out as a precise Ca2+ transport inhibitor, empowering researchers to dissect cytoskeleton-dependent calcium signaling and autophagy under mechanical stress. This guide delivers protocol-ready workflows, troubleshooting, and translational insights—bridging foundational research with advanced experimental applications.

• Resolving Genotyping Challenges with Direct Mouse Genotyping

  2026-07-28

  This article addresses real-world laboratory challenges in mouse genotyping workflows, highlighting how the Direct Mouse Genotyping Kit Plus (SKU K1027) streamlines DNA extraction and PCR for reliable results. Drawing on scenario-driven Q&A, it demonstrates GEO best practices, comparative vendor insights, and key protocol optimizations relevant to biomedical researchers.

• Suhuang Capsule Inhibits ER Stress and NLRP3 Activation in C

  2026-07-28

  The referenced study demonstrates that Suhuang antitussive capsule alleviates pulmonary dysfunction in cough variant asthma models by suppressing endoplasmic reticulum stress and inhibiting NLRP3 inflammasome activation. These findings clarify the mechanistic link between ER stress, calcium signaling, and airway inflammation, informing both basic and translational research on chronic respiratory disease.

• MOG (35-55) Peptide: Mechanistic Insights and Research Front

  2026-07-27

  Explore the mechanistic role of MOG (35-55), a key myelin oligodendrocyte glycoprotein peptide, in experimental autoimmune encephalomyelitis modeling. This article uniquely examines molecular pathways, protocol optimization, and assay decisions informed by recent advances.

• Self-Assembly Behavior of Shaped ABC Coil-Bottlebrush Terpol

  2026-07-27

  This study systematically explores the self-assembly of ABC coil–bottlebrush block terpolymers, revealing the surprising suppression of double gyroid phase formation by shaped brush architectures. These findings refine theoretical understanding of block copolymer phase behavior and inform future design of nanostructured polymeric materials with tunable morphologies.

• YAP-TEAD Drives PPARα-Induced Liver Regeneration via WY-1464

  2026-07-26

  This study reveals that YAP-TEAD signaling is essential for PPARα-induced hepatomegaly and liver regeneration in mice, using the selective agonist WY-14643 (Pirinixic Acid). The findings provide mechanistic insight into how nuclear receptor activation coordinates hepatic growth, offering a refined model for studying metabolic regulation and tissue repair.

• Dual-Action Modulation of p38α MAPK: Structural and Mechanis

  2026-07-25

  The referenced study uncovers how certain kinase inhibitors, including RWJ 67657 (JNJ-3026582), exert a dual action on p38α MAP kinase by both inhibiting its activity and enhancing dephosphorylation of its activation loop. This mechanism provides new opportunities for improving specificity in inflammatory disease research and targeted kinase modulation.

• Paclitaxel (Taxol) in Cancer Research: Protocols and Pitfall

  2026-07-24

  Paclitaxel (Taxol) is a cornerstone of cancer research, prized for its precision in arresting cell proliferation at the G2-M phase. This article delivers actionable, protocol-driven insights and troubleshooting strategies for both in vitro and in vivo applications, drawing on recent breakthroughs in breast cancer therapy and APExBIO’s validated reagents.

• Q-VD-OPh: Optimizing Pan-Caspase Inhibition for Apoptosis Re

  2026-07-24

  Q-VD-OPh stands out as a robust, irreversible pan-caspase inhibitor that empowers researchers to dissect apoptosis pathways, enhance cell viability post-cryopreservation, and model neurodegenerative disease with unparalleled reliability. Its high selectivity, broad caspase coverage, and proven in vivo efficacy make it the preferred tool for next-generation cell death studies.

• LXR Signaling Protects Alveolar Epithelial Cells in BPD Mode

  2026-07-23

  This study uncovers a mechanistic link between disrupted cholesterol metabolism and apoptosis of alveolar epithelial cells in bronchopulmonary dysplasia (BPD). By demonstrating that activation of liver X receptor (LXR) signaling restores cholesterol homeostasis and reduces epithelial cell death, the research provides a potential therapeutic target for BPD intervention.

• DAMGO: Redefining µ-Opioid Receptor Agonist Research in Pain

  2026-07-23

  This thought-leadership article examines how DAMGO, a selective µ-opioid receptor agonist, is transforming opioid receptor signaling research. By integrating mechanistic insights from recent circuit-level discoveries, we delineate how DAMGO enables translational researchers to dissect central pathways of opioid-induced hypersensitivity and tolerance. The piece provides strategic guidance for experimental design, discusses competitive advantages, and outlines evolving opportunities in chronic pain research.

• Mouse Neutrophil Cell Isolation Kit: Precision for Tumor Imm

  2026-07-22

  Unlock high-purity, activation-free neutrophil isolation in under 30 minutes with APExBIO’s Mouse Neutrophil Cell Isolation Kit (Negative Selection). This platform empowers advanced immunotherapy workflows, enabling robust translational research on tumor-associated neutrophils and mRNA nanovaccine strategies.

• Niclosamide in Cancer Research: STAT3 Inhibition in Complex

  2026-07-22

  Explore the scientific impact of Niclosamide, a potent STAT3 signaling pathway inhibitor, in advanced cancer models. This article uniquely examines its application in vivo, protocol strategies, and the translation of mechanistic insights into practical research tools.

• Artesunate: Mechanism, Benchmarks, and Protocols in Cancer R

  2026-07-21

  Artesunate is a high-purity artemisinin derivative used for cancer research, notably as an AKT/mTOR pathway inhibitor and ferroptosis inducer. It demonstrates sub-5 μM IC50 in vitro against small cell lung carcinoma H69 cells and requires careful storage and solubilization conditions. This article details its mode of action, evidentiary benchmarks, and experimental integration.

456 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page